LC crashed CHM????? Don't lump them together, I agree PH is greedy and that's why I'm greedy. I'm not attacking you, I'm just stating facts that you cross promoted CHM a few years ago and done the same for RAD and seemingly ignore what others have corrected you on.
I'm not sure where you got the information that dose escalation was ever stopped for VAXINIA??? IMU haven't determine the OBD and there hasn't been any toxicity so the Ph1 clinical trial has been going as expected to determine OBD for Ph2 clinical trial. There was toxicity for Azer-Cel, @Mason14 mentioned this and questioned it before the excellent clinical trial update for Azer-Cel which was why the update for Cohort A was poor until a small dosage of IL-2 was combined with Azer-Cel for Cohort B, didn't I already tell you this when you asked last time as it probably does explain why there was no interest from Novartis and why IMU acquired the IP relatively cheap. Anyway, the purchase of Azer-Cel was for CD19 used in the OASIS clinical trial.
IMU Price at posting:
3.9¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)